Anne‐Marie Duliège

Author

Anne‐Marie Duliège

Also Known As

A DULIEGE, A M Duliege, A. M. Duliege, A.-M. Duliege, A.M. Duliege, A.‐M. Duliege, Anne-Marie Duliege, Anne-Marie Duliège, Anne‐Marie Duliege, Anne‐Marie Duliegè

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Affymax (United States)Johns Hopkins University King's College Hospital Saint Louis University National Institutes of Health

About

Anne‐Marie Duliège is an author at Affymax (United States) specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.1K
2	Health Sciences	3	3	479
3	Allergy	3	3	115
4	Public Health	1	1	14
5	Cell Biology	1	1	15

Anne‐Marie Duliège

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials James B. Bussel, Donald M. Arnold, Elliot Grossbard, American Journal of Hematology Clinical ImmunologyImmunodeficienciesImmunologyImmune RegulationItp Patients	2018	329
A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant Robert F. Pass, Anne‐Marie Duliège, Suresh B. Boppana, The Journal of Infectious Diseases	1999	247
Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers Guido Ferrari, Will Humphrey, M. Juliana McElrath, Proceedings of the National Academy of Sciences	1997	227
Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV‐1<sub>Mn</sub>gp120, HIV‐1<sub>SF2</sub>Recombinant gp120, or Both Vaccines in Seronegative Adults Mary Lou Clements‐Mann, Kent J. Weinhold, Thomas J. Matthews, The Journal of Infectious Diseases ImmunodeficienciesImmunologyImmunodominanceHiv-1sf2 Neutralizing AntibodiesHuman Immunodeficiency Virus	1998	190
Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers Robert B. Belshe, Geoffrey J. Gorse, Mark J. Mulligan, AIDS	1998	171
A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia Iain C. Macdougall, Jérôme Rossert, Nicole Casadevall, New England Journal of Medicine	2009	156
Safety and Immunogenicity of a Canarypox‐Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher‐ and Lower‐Risk Volunteers Robert B. Belshe, Cladd E. Stevens, Geoffrey J. Gorse, The Journal of Infectious Diseases	2001	144
Peginesatide for Anemia in Patients with Chronic Kidney Disease Not Receiving Dialysis Iain C. Macdougall, Robert Provenzano, Amit Sharma, New England Journal of Medicine	2013	119
Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program James B. Bussel, Donald M. Arnold, Michael Boxer, American Journal of Hematology ImmunodeficienciesImmunologyPharmacotherapyImmunotherapyDouble-blind Fostamatinib	2019	116
Peginesatide in Patients with Anemia Undergoing Hemodialysis Steven Fishbane, Brigitte Schiller, Francesco Locatelli, New England Journal of Medicine	2013	111

Page 1